Imagine precisely treating a cancerous tumor based on its exact shape and exact location – whether it is embedded in the brain or somewhere deep within the body – and never using an incision. That’s what specialists in Henry Ford’s Radiation Oncology Department are doing with the world’s most sophisticated shaped beam radiosurgery (or focused radiation) technology and procedures.
Henry Ford was the first institution in the world to use stereotactic radiosurgery on tumors of the spine and spinal cord, and treats more than 500 patients annually with radiosurgery for the spine, lung, liver, adrenal gland and pancreas, making Henry Ford a highly experienced, world renowned radiosurgery institution. Radiosurgery is discussed in designated tumor boards, including the weekly spine tumor board which is unique to Henry Ford. In addition, radiosurgery team members are requested to lecture at national meetings, workshops and symposiums. The Henry Ford radiosurgery team continues to conduct clinical trials, as well as basic science and clinical research in an effort to benefit patients.
Stereotactic radiosurgery is a precise, non-invasive procedure that involves targeting beams of radiation at a specific area of a tumor to shrink or destroy cancerous cells. Because no incision is required, radiosurgery avoids complications and recovery times associated with surgery.
Precise focusing of a high dose of radiation is accomplished through the use of stereotactic localization, digital imaging techniques, such as CT, MRI and angiography, and computerized three-dimensional treatment planning with intensity modulation. The actual treatment performed is completed in about 30 minutes and the patient can resume normal activities that day.
Before Radiosurgery
After Radiosurgery
At Henry Ford, the common indications of radiosurgery for primary and metastatic tumors are, but not limited to, the following:
